| [1] |
刘军,公伟,杨凤辉,等. 肝脏移植治疗自身免疫性肝炎2例报告并文献复习.器官移植,2010,1: 173-175.
|
| [2] |
陈智敏,史政荣,杜成友,等.自身免疫性肝炎肝移植术后激素的应用.重庆医科大学学报,2014,39:986-989.
|
| [3] |
刘士敬. 自身免疫性肝炎治疗标准.中国社区医师,2010, 26: 8.
|
| [4] |
Khalaf H, Mourad W, El-Sheikh Y, et al. Liver transplantation for autoimmune hepatitis: a single-center experience. Transplant Proc, 2007, 39: 1166-1170.
|
| [5] |
邱月虹, 吕志武. 自身免疫性肝炎的研究进展. 肝脏,2015,20: 81-83.
|
| [6] |
史瑞, 沈中阳. 肝脏移植中糖皮质激素的应用.实用器官移植电子杂志,2014,2: 206-211.
|
| [7] |
Campsen J, Zimmerman M, Trotter JF, et al. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl,2008,14:1281-1286.
|
| [8] |
Czaja AJ. Diagnosis,pathogenesis,and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci,2012,57:2248-2266.
|
| [9] |
Czaja AJ. Promising pharmacological,molecular and cellular treatments of autoimmune hepatitis. Curr Pharm Des,2011,17:3120-3140.
|
| [10] |
Manns M,Lohse AW,Vergani D.Autoimmune hepatitis-Update 2015.J Hepatol,2015,62(1 Suppl): S100-S111.
|
| [11] |
梁德娇, 梁列新, 张法灿. 自身免疫性肝炎的诊疗研究进展. 广西医学,2016,38: 987-990.
|
| [12] |
European Association for the Study of the Liver.EASL clinical practice guidelines: autoimmune hepatitis J Hepatol,2015,63: 971-1004.
|
| [13] |
CZAJA AJ.Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Aliment Pharmacol Ther,2014,39: 385 -406.
|
| [14] |
杨志勇, 宋海林. 自身免疫性肝炎的诊断与治疗.现代诊断与治疗,2014,25: 4781-4782.
|
| [15] |
Manns MP, Czaja AJ, Gorham JD,et al. Diagnosis and management of autoimmune hepatitis (AASLD practice guide lines). Hepatology,2010,51: 2193-2213.
|
| [16] |
曹忆嵘, 郭津生, 彭利军, 等. 52例自身免疫性肝炎的临床特点及其治疗. 肝脏, 2012, 17: 6-10.
|
| [17] |
CZAJA AJ. Autoimmune hepatitis in special patient populations.Best Pract Res Clin Gastroenterol,2011,25: 689-700.
|
| [18] |
李磊,刘静.硫唑嘌呤致白细胞减少1例. 医药导报,2016,35: 541-542.
|
| [19] |
逄晓云,刘晓琰. 硫唑嘌呤致严重骨髓抑制1例.中国药物警戒,2015,12: 59-60.
|
